Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2018 / Articles / Jan / Battling the Bugs
Manufacture Small Molecules

Battling the Bugs

London’s Science Museum highlights superbugs and the stars that fight against them in a new exhibition

By Stephanie Vine 01/17/2018 1 min read

Share

What?
“Superbugs: The Fight For Our Lives” is a free exhibition in London that highlights the danger that antibiotic resistance poses to human health, as well as the stories of those tackling the issue head-on. Some of the displays included in the exhibition are 12 real bacterial colonies (including nine classified by the World Health Organization as a significant threat to human health), penicillium mould recently grown from Fleming’s original samples, 14,000 pills that illustrate the two-year treatment needed to combat multi-drug resistant tuberculosis, and an interactive game where visitors can try to halt the worldwide spread of a superbug. It will also be possible to learn about Komodo dragon blood and watch as researchers from the University of Illinois dive into Icelandic fjords – both potential sources of new antibiotics. Experts will share thoughts on superbugs and how to prevent them from spreading. Four prototypes made by teams across the globe vying for the £8-million Longitude Prize will also be on display for the first time. Submissions for the Longitude Prize launched in 2014 – the goal: to invent an affordable, accurate, rapid and easy to use test for bacterial infections that will allow health professionals to administer the right antibiotics at the right time.

Why?
According to the exhibition, superbugs today kill almost 700,000 each year – a figure that could rise to 10 million by 2050. Tackling the issue requires both public awareness and collaboration between industry, governments and health providers in the creation of new policies, educational programs and medical interventions.
Who?
The exhibition is sponsored by Pfizer and Shionogi, and supported by UK Research and Innovation and the University of East Anglia.

Where?

The Science Museum, London, UK.

When?

The exhibition will run until April 2019.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

More Articles by Stephanie Vine

False

Advertisement

Recommended

False

Related Content

The Final Frontier?
Small Molecules
The Final Frontier?

December 1, 2014

0 min read

The Galactic Grant Competition encourages companies to use the International Space Station for pharmaceutical R&D

Calculate – Don’t Estimate – Drug Development Costs
Small Molecules
Calculate – Don’t Estimate – Drug Development Costs

December 1, 2014

0 min read

Researchers estimate the cost of drug development at over $1 billion, while others say it’s less than $100 million. Who’s right? And how can we accurately determine the true costs?

Electrifying R&D Acceleration
Small Molecules Analytical Science
Electrifying R&D Acceleration

December 2, 2014

0 min read

Electrochemical reaction cells are finding new applications in the pharma R&D lab that could offer big time and cost savings...

United Science Stands
Small Molecules Standards & Regulation
United Science Stands

December 2, 2014

0 min read

Sitting Down With… William Chin, Executive Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA).

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.